Continuing Pharmacy Education (CPE) Activities

Credits: 1.00 CME / MOC / CC / CNE / CPE
Medical Learning Institute, Inc.
It's Precisely the Time for More Precision in Genomic Testing and Targeted Treatment of NSCLC
Rebecca S. Heist, MD, MPH
July 23, 2020
Credits: 1.00 CME / MOC / CPE
Medical Learning Institute, Inc.
Teaming Up to Reduce the Burden of Cancer-Associated VTE: Applying the Latest Guidelines and Evidence in Gastrointestinal and Hematologic Malignancies and Other Cancer Settings
Alok A. Khorana, MD, FACP, FASCO
July 2, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
June 30, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Finding the Path to Clinically Meaningful Outcomes Among Expanding Treatment Options in Renal Cell Carcinoma
Hans J. Hammers, MD, PhD
June 18, 2020
Credits: 0.50 CME / MOC / CPE
Medical Learning Institute, Inc.
Chair’s Take on Cancer-Associated VTE: Highlights From Recent Science
Alok A. Khorana, MD, FACP, FASCO
June 11, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Deep Insight Into Immuno-Oncology: A Visual Exploration of Current and Emerging Pathways, Targets, and Biomarkers to Maximize the Potential of Cancer Immunotherapies
Nadeem Riaz, MD, MSc
May 29, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Purdue University
Biosimilars as Partners in Oncology: Expert Guidance on Understanding and Incorporating Biosimilar Agents in Real-World Care
Hope S. Rugo, MD, FASCO
April 28, 2020

Pages